Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Raw Materials (2022 - 2026)

HeartSciences' Raw Materials history spans 5 years, with the latest figure at $375902.0 for Q1 2026.

  • For Q1 2026, Raw Materials rose 16.38% year-over-year to $375902.0; the TTM value through Jan 2026 reached $375902.0, up 16.38%, while the annual FY2025 figure was $347036.0, 7.44% up from the prior year.
  • Raw Materials reached $375902.0 in Q1 2026 per HSCS's latest filing, up from $322996.0 in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $375902.0 in Q1 2026 to a low of $322996.0 in Q2 2023.
  • Average Raw Materials over 5 years is $337047.4, with a median of $322996.0 recorded in 2023.
  • Peak YoY movement for Raw Materials: decreased 10.27% in 2023, then grew 16.38% in 2026.
  • A 5-year view of Raw Materials shows it stood at $359965.0 in 2022, then fell by 10.27% to $322996.0 in 2023, then changed by 0.0% to $322996.0 in 2024, then changed by 0.0% to $322996.0 in 2025, then increased by 16.38% to $375902.0 in 2026.
  • Per Business Quant, the three most recent readings for HSCS's Raw Materials are $375902.0 (Q1 2026), $322996.0 (Q4 2025), and $322996.0 (Q3 2025).